Canadian Chronic Disease Surveillance System (CCDSS)

Select item(s) from each list below:

Geography

Condition

Measure

Sex
Both sexes
Males Females
Use the same vertical axis scale across all sex categories

Optional:

Year range

Scale
Use the same vertical axis scale across all geographic areas

Chart type
Line Bar

For more information on the interpretation of the data please see the notes below.

Summary Table: Ischemic heart disease, age-standardized incidence rate, per 100,000, age 20 years and older, Canada
Sex	Fiscal year	Rate (per 100,000)	95% CI	CV (%)	Counts
Both sexes	2000–2001	1,239	1,234–1,245	0.22	217,465
Both sexes	2001–2002	1,149	1,144–1,154	0.22	204,410
Both sexes	2002–2003	1,070	1,065–1,075	0.23	194,070
Both sexes	2003–2004	1,013	1,008–1,018	0.23	187,100
Both sexes	2004–2005	959	955–964	0.24	180,950
Both sexes	2005–2006	915	910–919	0.24	176,115
Both sexes	2006–2007	862	858–866	0.25	169,700
Both sexes	2007–2008	828	824–832	0.25	166,660
Both sexes	2008–2009	800	796–804	0.25	167,105
Both sexes	2009–2010	761	758–765	0.25	163,420
Both sexes	2010–2011	737	733–740	0.25	162,605
Both sexes	2011–2012	710	707–714	0.25	161,135
Both sexes	2012–2013	680	677–683	0.25	158,710
Both sexes	2013–2014	657	653–660	0.25	157,815
Both sexes	2014–2015	639	636–642	0.25	157,225
Both sexes	2015–2016	630	627–633	0.25	159,230
Both sexes	2016–2017	627	624–630	0.25	163,110
Both sexes	2017–2018	611	608–614	0.25	163,290
Both sexes	2018–2019	590	587–593	0.25	162,255
Both sexes	2019–2020	589	586–591	0.25	166,545
Both sexes	2020–2021*	546	543–548	0.26	157,395
Both sexes	2021–2022*	569	567–572	0.25	164,945
Both sexes	2022–2023*	553	550–556	0.25	165,165
Males	2000–2001	1,528	1,519–1,537	0.30	117,190
Males	2001–2002	1,412	1,403–1,420	0.32	109,765
Males	2002–2003	1,323	1,314–1,331	0.32	105,350
Males	2003–2004	1,256	1,248–1,264	0.33	102,090
Males	2004–2005	1,201	1,193–1,209	0.33	100,030
Males	2005–2006	1,153	1,146–1,161	0.33	98,145
Males	2006–2007	1,089	1,082–1,097	0.34	95,105
Males	2007–2008	1,057	1,050–1,064	0.34	94,360
Males	2008–2009	1,020	1,013–1,027	0.34	94,620
Males	2009–2010	964	957–970	0.34	92,175
Males	2010–2011	939	933–945	0.34	92,435
Males	2011–2012	905	899–911	0.34	91,770
Males	2012–2013	871	865–877	0.34	90,790
Males	2013–2014	846	840–851	0.34	91,125
Males	2014–2015	822	816–827	0.34	90,610
Males	2015–2016	808	803–813	0.34	91,820
Males	2016–2017	807	802–813	0.33	94,525
Males	2017–2018	784	779–790	0.33	94,345
Males	2018–2019	756	751–761	0.33	93,790
Males	2019–2020	756	751–761	0.33	96,620
Males	2020–2021*	697	692–701	0.34	90,795
Males	2021–2022*	719	715–724	0.33	94,370
Males	2022–2023*	700	695–704	0.33	94,430
Females	2000–2001	1,009	1,002–1,015	0.32	100,270
Females	2001–2002	939	933–945	0.33	94,650
Females	2002–2003	866	860–872	0.34	88,720
Females	2003–2004	816	810–821	0.35	85,010
Females	2004–2005	763	758–768	0.35	80,920
Females	2005–2006	721	716–726	0.36	77,975
Females	2006–2007	676	671–681	0.37	74,595
Females	2007–2008	642	637–646	0.37	72,305
Females	2008–2009	620	616–625	0.37	72,490
Females	2009–2010	595	590–599	0.38	71,250
Females	2010–2011	570	566–574	0.38	70,175
Females	2011–2012	549	545–553	0.38	69,365
Females	2012–2013	522	518–526	0.39	67,920
Females	2013–2014	500	496–504	0.39	66,690
Females	2014–2015	487	484–491	0.39	66,615
Females	2015–2016	482	478–486	0.39	67,410
Females	2016–2017	476	473–480	0.38	68,585
Females	2017–2018	466	462–469	0.38	68,945
Females	2018–2019	450	447–454	0.39	68,460
Females	2019–2020	448	444–451	0.38	69,930
Females	2020–2021*	418	415–421	0.39	66,605
Females	2021–2022*	442	439–446	0.38	70,580
Females	2022–2023*	429	426–432	0.38	70,735

Download Detailed Table:
Ischemic heart disease, age-standardized incidence rate

Download Summary Table

Notes:

*Many CCDSS measures, such as chronic disease incidence, were influenced by the COVID-19 pandemic. Changes in such measures may be driven by multiple factors, including (but not limited to) differences in healthcare seeking behaviour, the availability and use of healthcare services, as well as true changes in health status. As such, CCDSS measures should be used cautiously when making inferences about population health during the COVID-19 pandemic. Guidance for data users on examining the impacts of the COVID-19 pandemic on CCDSS measures can be accessed below.
Data suppression: Estimates are not reported when the counts are less than 10 or the coefficient of variation is greater than 33.3%.
Due to periodic updates of the historical surveillance data, estimates for a particular disease and year may change over time, and may not be comparable to previous editions.
Estimates are age-standardized to the 2011 Canadian population using unrounded counts and five-year age groups. Age-standardized estimates are useful for comparing data across years or between different geographical areas, but they do not reflect the actual impact of the disease.
Nunavut data are excluded before 2005–2006.
Newfoundland and Labrador data are excluded before 2008–2009.
Yukon data are excluded before 2010–2011.
The modernization of the Quebec billing system for fee-for-service medical services by the Régie de l'assurance maladie du Québec (RAMQ) in 2016 has resulted in a decrease in the entry of diagnostic codes in the fee-for-service medical services file. Data for 2016–2017 and subsequent years should therefore be interpreted with caution, as a slight underestimation is suspected.
The introduction of the Northwest Territories Electronic Medical Record (EMR) in 2016 resulted in more complete and consistent data. Data for 2016–2017 may be slightly underestimated compared to previous years due to the system transition.
New Brunswick data were not available for 2021–2022 and 2022–2023.
Northwest Territories data were not available for 2022–2023.
Northwest Territories physician claim data were incomplete for 2021–2022 and should therefore be interpreted with caution, as a slight underestimation is suspected.

Source: Canadian Chronic Disease Surveillance System 2024
Methods: CCDSS Summary of Methods
Case definitions: CCDSS Case Definitions
COVID-19 Documentation: CCDSS COVID-19 guidance for data users

Acknowledgements

These data were made possible through collaboration between PHAC and the respective provincial and territorial governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Northwest Territories, Yukon, and Nunavut. No endorsement by the provinces and territories is intended or should be inferred. Provincial and territorial data were contributed to the CCDSS as of July 2024.

Did you find what you were looking for?

What was wrong?

The answer I need is missing

The information isn’t clear

I’m not in the right place

Something is broken or incorrect

Other reason

Please provide more details

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Report a problem or mistake on this page

Date modified:: 2024-10-15

Language selection

Search

Canadian Chronic Disease Surveillance System (CCDSS)

Select item(s) from each list below:

Optional:

Acknowledgements

Did you find what you were looking for?